|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/519 | |
| A61K 39/00 | |||
| A61K 31/505 | |||
| A61K 45/06 | |||
| A61P 29/00 | |||
| C07K 16/24 | |||
| A61K 39/395 |
| (11) | Number of the document | 2101780 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07868831.4 |
| Date of filing the European patent application | 2007-11-21 | |
| (97) | Date of publication of the European application | 2009-09-23 |
| (45) | Date of publication and mention of the grant of the patent | 2013-10-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/085402 |
| Date | 2007-11-21 |
| (87) | Number | WO 2008/064321 |
| Date | 2008-05-29 |
| (30) | Number | Date | Country code |
| 860780 P | 2006-11-21 | US | |
| 902742 P | 2007-02-21 | US |
| (72) |
BEBBINGTON, Christopher R., US
YARRANTON, Geoffrey T., US
|
| (73) |
Kalobios Pharmaceuticals, Inc.,
260 East Grand Avenue, South San Francisco, CA 94080,
US
|
| (54) | METHODS OF TREATING CHRONIC INFLAMMATORY DISEASES USING A GM-CSF ANTAGONIST |
| METHODS OF TREATING CHRONIC INFLAMMATORY DISEASES USING A GM-CSF ANTAGONIST |